“merrimack-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Ex-Merrimack, Seragon Execs’ New Startup Gets $60M, Buys Sanofi Drug 02/01/18 Boston
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Merrimack Hits Reset Button, Sells Cancer Drugs to Ipsen For $575M 01/08/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More 11/11/16 National
Bio Roundup: Jenkins Gets Mad, Bernie Gets His Pen, CRISPR IPO & J-Lo 10/21/16 National
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns 10/03/16 Boston
Credit Suisse Banker Takes on CFO Role at Merrimack 08/06/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Merrimack, Baxter Ink $970M+ Deal for Pancreatic Cancer Drug 09/24/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Merrimack’s Cancer Drug Misses Mark in Mid-Stage Trial, Shares Tumble 10/30/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Merrimack Aims For Penny-Wise Pipeline of Cancer Drugs 05/24/13 Boston
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
Page 1 of 2 next page »